ProCE Banner Activity

CE

New Approaches to Myeloma Treatment: What You Need to Know and What You Need to Tell Your Patients

Multimedia
In this archived webcast from the CCO management of patients with myeloma live meeting series, Joseph D. Tariman, PhD, ANP-BC, provides expert perspective on ways that nurses can help optimize treatment choices for patients with advanced myeloma through shared decision making.
Registered Nurses : 1.00 Nursing contact {hour}

Released: December 23, 2016

Expiration: December 22, 2017

No longer available for credit.

Share

Faculty

Joseph D. Tariman

Joseph D. Tariman, PhC, MN, APRN, BC, OCN

Predoctoral Fellow, Dept. of Biobehavioral Nursing and Health Systems
Fellow, Achievement Rewards for College Scientists (ARCS) Foundation
School of Nursing
University of Washington
Seattle, Washington

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Celgene

Novartis Oncology

Target Audience

This activity is intended for oncology nurses and other healthcare providers who provide care for patients with multiple myeloma.

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Describe specific strategies to engage patients with multiple myeloma and their caregivers in shared decision making to make them an active participant in their care
  • Educate patients with multiple myeloma on the anticipated adverse events of various treatment options so that they will be empowered to participate in treatment decision making
  • Interact with patients with multiple myeloma and caregivers to evaluate resources for continuous education and support as a source of empowerment

Faculty Disclosure

Primary Author

Joseph D. Tariman, PhC, MN, APRN, BC, OCN

Predoctoral Fellow, Dept. of Biobehavioral Nursing and Health Systems
Fellow, Achievement Rewards for College Scientists (ARCS) Foundation
School of Nursing
University of Washington
Seattle, Washington

Joseph D. Tariman, PhD, ANP-BC, has reported that he has no real or apparent financial conflicts to disclose.

Staff Disclosure

Staff

Terrence Fagan,

Associate Scientific Director

Terrence Fagan has no real or apparent conflicts of interest to report.

Gordon Kelley,

Clinical Editor
Clinical Care Options, LLC

Gordon Kelley has no real or apparent conflicts of interest to report.

Kevin Obholz, PhD

Editorial Director, Hematology/Oncology

Kevin Obholz, PhD, has no real or apparent conflicts of interest to report.

Instructions for Credit

Accreditation Statement

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation

1.0 contact hour may be earned for successful completion of this activity.

Additional Information

Participation in this self-study activity should be completed in approximately 1 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from December 23, 2016, through December 22, 2017:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.


Goal


The goal of this activity is to provide education and tools that help oncology nurses provide optimal care for patients with multiple myeloma within a shared decision making framework.